Frost & Sullivan: Diagnostic and Therapeutic Potential of microRNAs Stimulate Need for More Research Tools

September 4, 2013

Product innovation and the development of high-qualitative assays are the need of the hour LONDON, Sept. 4, 2013 /PRNewswire/ — Rapid growth in microRNA (miRNA) research over the past two years, owing to its diagnostic and therapeutic potential, has fueled development in the global miRNA tools and services market. Of the various miRNA technologies, which include quantitative […]

Read the full article →

Call for Papers

April 16, 2013

Call for papers for an open special issue on small/microRNAs: Small RNAs: Revolutionizing the Genomics Landscape The editors invite researchers to contribute original research articles as well as review articles focused on the use, development, or the application of genomics tools for investigating the role of small RNAs at the whole-genome level. The editors will […]

Read the full article →

Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 AACR Anual Meeting

April 8, 2013

NEW YORK, April 8, 2013 /PRNewswire/ — Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostics for use in personalized medicine, today announced that the company is presenting a late-breaking abstract at the AACR Annual Meeting 2013, in Washington D.C.  The abstract is titled “Exosome profiling of mRNAs and miRNAs in serum samples from GBM (glioblastoma […]

Read the full article →

Antiviral Drug Miravirsen: Final Phase 2a results show dose-dependent, prolonged antiviral activity in Hepatitis C patients

March 27, 2013

Research Published in the New England Journal of Medicine Demonstrates Marked and Long-Lasting Antiviral Activity Against HCV for Santaris Pharma A/S’ Miravirsen, the First MicroRNA-Targeted Drug to Enter Clinical Trials HOERSHOLM, Denmark and SAN DIEGO, March 27, 2013 /PRNewswire/ — Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted […]

Read the full article →

Rosetta Genomics Receives 25th U.S. Patent Allowance

March 18, 2013

Award Strengthens Growing Portfolio of microRNAs in Viral Infection PHILADELPHIA and REHOVOT, Israel, March 18, 2013 /PRNewswire/ — Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces receipt of a Notice of Allowance from the U.S. Patent Office related to U.S. Patent Application No. 12/517,760 entitled “Nucleic Acids Involved in […]

Read the full article →

Signature MicroRNA Expression Patterns Identified in Humans with 22q11.2 Deletion/DiGeorge Syndrome

February 26, 2013

Researchers at the University of Texas Southwestern Medical Center and Baylor Institute for Immunology Research have identified a novel expression signature in patients with DiGeorge Syndrome. DiGeorge Syndrome occurs because of a chromosomal deletion in 22q11.2, resulting in the hemizygous deletion of > 60 genes and 4 microRNAs. Peripheral blood taken from 31 DiGeorge Syndrome […]

Read the full article →

New Release: The UEA Small RNA Workbench Version 3.0 (Alpha)

February 15, 2013

The UEA sRNA Workbench is a collection of software tools specifically designed to identify and analyze features in small RNA data. Yesterday, the Alpha release of The UEA Small RNA Workbench Version 3.0 was announced.  This release includes a brand new tool for general small RNA locus detection called CoLIde. For more information and  some […]

Read the full article →

Firefly BioWorks Announces New Grant for microRNA Research

February 11, 2013

Dr. Davide Marini, co-founder and Chief Executive Officer of Firefly BioWorks announced today the creation of the Firefly Frontiers Grant: “We are excited to provide financial support to researchers for expanding the horizons of microRNA research. We encourage applicants to explore high-impact questions and those high-risk explorations that would not be normally funded through a traditional […]

Read the full article →

miRNAs and Bladder Cancer – Study Validating Ability of microRNAs to Predict Progression

February 7, 2013

NOTE: hsa-miR-29c* mentioned in the following paper is the retired name for what is now hsa-miR-29c-5p: http://www.mirbase.org/cgi-bin/mature.pl?mature_acc=MIMAT0004673 PHILADELPHIA and REHOVOT, Israel, Feb. 7, 2013 /PRNewswire/ — Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that data from a study demonstrating the ability of microRNA expression to serve as […]

Read the full article →

Review – Virus-Encoded microRNAs

February 5, 2013

An Overview and a Look to the Future Kincaid & Sullivan recently published a review paper summarizing the current state of viral miRNA research. While microRNAs (miRNAs) were initially described as posttranscriptional gene regulators in eukaryotic hosts, virus-encoded miRNAs were later uncovered. It is now apparent that diverse virus families, most with DNA genomes, but […]

Read the full article →